HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haiyang Chen Selected Research

Transcription Factors (Transcription Factor)

11/2021Research progress of DLX6-AS1 in human cancers.
1/2010Silencing MR-1 attenuates inflammatory damage in mice heart induced by AngII.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haiyang Chen Research Topics

Disease

8Neoplasms (Cancer)
11/2021 - 01/2015
6Inflammation (Inflammations)
01/2021 - 11/2014
5Rectal Neoplasms (Rectal Cancer)
01/2022 - 01/2019
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 11/2016
3Neoplasm Metastasis (Metastasis)
01/2019 - 06/2013
3Carcinogenesis
01/2015 - 04/2012
2Adenocarcinoma of Lung
06/2022 - 12/2020
2Liver Neoplasms (Liver Cancer)
11/2021 - 01/2015
2Lung Neoplasms (Lung Cancer)
11/2021 - 10/2017
2Hyperplasia
01/2021 - 11/2014
2Infections
01/2021 - 09/2016
2Nasopharyngeal Carcinoma
01/2019 - 10/2015
2Breast Neoplasms (Breast Cancer)
01/2015 - 06/2013
2Cysts
01/2014 - 07/2013
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2021
1Adenocarcinoma
04/2021
1Microsatellite Instability
04/2021
1Carcinoma (Carcinomatosis)
01/2021
1Neuroblastoma
01/2021
1Human Influenza (Influenza)
12/2020
1Lung Injury
12/2020
1Pathologic Complete Response
10/2020
1Colorectal Neoplasms (Colorectal Cancer)
05/2020
1Mitochondrial Diseases (Mitochondrial Disease)
05/2020
1Epstein-Barr Virus Infections
01/2020
1Colitis
01/2020
1Squamous Cell Carcinoma of Head and Neck
04/2016
1Disease Progression
04/2016
1Genomic Instability
01/2016
1Stomach Neoplasms (Stomach Cancer)
12/2015

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2010
4DNA (Deoxyribonucleic Acid)IBA
11/2021 - 04/2015
4Pharmaceutical PreparationsIBA
01/2021 - 01/2015
4Lamin Type B (Lamin B)IBA
01/2016 - 01/2014
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2019
2Tyrosine Kinase InhibitorsIBA
06/2022 - 12/2020
2ChromatinIBA
01/2022 - 11/2021
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 12/2020
2Transcription Factors (Transcription Factor)IBA
11/2021 - 01/2010
2RNA (Ribonucleic Acid)IBA
11/2021 - 04/2015
2Messenger RNA (mRNA)IBA
01/2021 - 06/2013
2NF-kappa B (NF-kB)IBA
01/2021 - 01/2010
2Cadherins (E-Cadherin)IBA
01/2019 - 12/2015
2LaminsIBA
01/2016 - 07/2013
2Glucose (Dextrose)FDA LinkGeneric
08/2013 - 01/2013
1Tyrosine (L-Tyrosine)FDA Link
06/2022
1ErbB Receptors (EGF Receptor)IBA
06/2022
1Phosphotransferases (Kinase)IBA
06/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1Competitive Endogenous RNAIBA
11/2021
1Long Noncoding RNAIBA
11/2021
1Calcibiotic Root Canal SealerIBA
04/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1thiazolyl blueIBA
01/2021
11- (diethylaminopropyl)- 4- phenylpiperazineIBA
01/2021
1mitogen and stress-activated protein kinase 1IBA
01/2021
1CrizotinibIBA
01/2021
1Bile Acids and Salts (Bile Acids)IBA
01/2021
1CurcuminIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1TaurineFDA Link
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
12/2020
1Biological ProductsIBA
12/2020
1Hematoxylin (Haematoxylon)IBA
12/2020
1EndotoxinsIBA
12/2020
1Anaplastic Lymphoma KinaseIBA
12/2020
1SeleniumIBA
05/2020
1Peptides (Polypeptides)IBA
05/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2020
1Matrix Metalloproteinases (MMPs)IBA
05/2020
1Small Interfering RNA (siRNA)IBA
05/2020
1Dextran SulfateIBA
01/2020
1StathminIBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
04/2018
1ElacridarIBA
10/2017
1Docetaxel (Taxotere)FDA Link
10/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2016
1Gefitinib (Iressa)FDA Link
11/2016
1Pattern Recognition ReceptorsIBA
09/2016
1SulfurIBA
04/2016
1IronIBA
04/2016
1DNA Transposable Elements (Element, IS)IBA
01/2016
1HeterochromatinIBA
01/2016
1TESIBA
01/2016
1Retroelements (Retrotransposon)IBA
01/2016
1CateninsIBA
12/2015
1pladienolide BIBA
04/2015
1Dopamine Receptors (Dopamine Receptor)IBA
01/2015

Therapy/Procedure

7Therapeutics
01/2022 - 01/2015
2Neoadjuvant Therapy
01/2022 - 10/2020
2Chemoradiotherapy
01/2022 - 01/2019
2Immunotherapy
11/2021 - 04/2021
2Drug Therapy (Chemotherapy)
11/2021 - 01/2019
2Radiotherapy
01/2019 - 10/2015
1Adjuvant Chemotherapy
10/2020